GH
Guardant HealthBNasdaq / Health Care Equipment & Services
Last Price
At close
2026-06-02
Current thesis
Successful scaling of commercial tests and favorable reimbursement lifts revenue and margins toward analyst highs.
Posture
Constructive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta +13.5.
What can break
Adverse reimbursement decisions limiting commercial uptake
Momentum
95
Value
36
Sentiment
37
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $113.84 · Bull $175.00 · Bear $55.00
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-02 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-02-20 • Model: RankAlpha Sentiment AI
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $132.57
Why
Momentum95 · Δ7d +13.5
Value36 · Δ7d -0.0
Sentiment37 · Δ7d -4.9
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
95
34% active weight
Current posture
7d trendFlat
Δ7d
+13.5
Δ21d
+49.8
Value
36
32% active weight
Current posture
7d trendFlat
Δ7d
-0.0
Δ21d
+0.1
Sentiment
37
33% active weight
Current posture
7d trendSoftening
Δ7d
-4.9
Δ21d
-22.1
Why this grade
Composite grade B. Momentum 95.5 / Value 36.4 / Sentiment 36.5
Fundamentals (TTM)As of 2026-06-02
Fundamentals (TTM)
As of 2026-06-02
Market Cap
$17.26B
Beta
1.64
Shares Out
128.84M
P/E (TTM) · Derived
-40.3
P/S (TTM)
14.54
P/FCF (TTM) · Derived
-63.42
Rev YoY
+38.5%
EPS YoY
+15.2%
Gross Margin
+63.8%
Op Margin
-48.1%
Net Debt
$302.57M
Current Ratio
3.50
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology